Skip to main content
Hemoglobin Testing Market by Technology, Product, End-user, and Geography - Forecast and Analysis 2020-2024

Hemoglobin Testing Market by Technology, Product, End-user, and Geography - Forecast and Analysis 2020-2024

Published: Sep 2020 120 Pages SKU: IRTNTR45223

The hemoglobin testing market has the potential to grow by USD 612.82 million during 2020-2024, and the market’s growth momentum will accelerate at a CAGR of 7.81%.

This hemoglobin testing market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Based on our research output, there has been a neutral impact on the market growth during and post COVID-19 era. The growing incidence of diabetes worldwide is notably driving the hemoglobin testing market growth, although factors such as limitations of hemoglobin testing may impede market growth. T

This report provides extensive insights on segmentations by end-user (healthcare centers, diagnostic laboratories, and others), technology (chromatography, immunoassay, and others), product (equipment and reagent and consumables), and geography (North America, Europe, Asia, and ROW). The hemoglobin testing market report also offers information on several market vendors, including Abbott Laboratories, ACON Laboratories Inc., Bayer AG, Bio-Rad Laboratories Inc., Danaher Corp., Diazyme Laboratories Inc., EKF Diagnostics Holdings Plc, F. Hoffmann-La Roche Ltd., Siemens AG, and Thermo Fisher Scientific Inc. among others.

What will the Hemoglobin Testing Market Size be in 2020?

Hemoglobin-Testing-Market-Market-Size-2019-2024

Browse TOC and LoE with selected illustrations and example pages of Hemoglobin Testing Market

 Get Your FREE Sample Now!

Hemoglobin Testing Market: Key Drivers and Trends

  • There is a growing prevalence of diabetes across the globe. The number of diabetic people across the world is expected to reach almost 150 million by 2025 because of the sedentary lifestyles, obesity, and lack of exercise. 
  • This will, in turn, create the demand for HCT blood tests and hemoglobin testing services across the globe since hemoglobin testing is an effective way of detecting blood glucose levels. 
  • With the increasing number of diabetic patients, the hemoglobin testing market will witness considerable growth.
  • There is also a growing preference for home care testing, because of the advantages including faster results, no waiting period between sample collection and analysis, and accurate results.
  • The rising demand for home care testing will be one of the key trends gaining traction in the hemoglobin testing market size.

This hemoglobin testing market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. 

Who are the Major Hemoglobin Testing Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

 

  • Abbott Laboratories
  • ACON Laboratories Inc.
  • Bayer AG
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • Diazyme Laboratories Inc.
  • EKF Diagnostics Holdings Plc
  • F. Hoffmann-La Roche Ltd.
  • Siemens AG
  • Thermo Fisher Scientific Inc.

 

The hemoglobin testing market is fragmented and the vendors are deploying growth strategies such as product differentiation to compete in the market. To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Which are the Key Regions for Hemoglobin Testing Market?

Hemoglobin-Testing-Market-Market-Share-by-Region-2019-2024

For more insights on the market share of various regions Request for a FREE sample now!

32% of the market’s growth will originate from North America during the forecast period. The US is one of the key markets for hemoglobin testing in North America. Market growth in this region will be slower than the growth of the market in Asia and Europe.

The technologically advanced healthcare and the high incidence of Type 1 and Type 2 diabetes will facilitate the hemoglobin testing market growth in North America over the forecast period. Infection such as mononucleosis is one of the top most common causes of splenomegaly.

What are the Revenue-generating End-user Segments in the Hemoglobin Testing Market?

Hemoglobin-Testing-Market-Market-Share-by-End-2019-2024

To gain further insights on the market contribution of various segments Request for a FREE sample

The healthcare centers comprise hospitals, clinics, and ambulatory surgery centers (ASCs). Hospitals and clinics are some of the most common types of healthcare facilities, where large numbers of patients seek treatment daily; therefore, they are better equipped in terms of advanced facilities and integrated operating rooms to cater to the growing needs of both physicians and patients. Therefore, the growth of the market segment is expected to be significant during the forecast period.

 

Event-Tickets-Market-Report

Request for a FREE sample

What are the Key Factors Covered in this Hemoglobin Testing Market Report?

  • CAGR of the market during the forecast period 2020-2024
  • Detailed information on factors that will drive hemoglobin testing market growth during the next five years
  • Precise estimation of the hemoglobin testing market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the hemoglobin testing industry across North America, Europe, Asia, and ROW
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of hemoglobin testing market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Table of Contents not available.

Research Methodology

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases

DATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts

REPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape

Interested in this report?

Get your sample now to see our research methodology and insights!

Download Now

Frequently Asked Questions

Hemoglobin Testing market growth will increase by 612.82 million during 2019-2024.

The Hemoglobin Testing market is expected to grow at a CAGR of 7.81% during 2019-2024.

Hemoglobin Testing market is segmented by Technology( Chromatography, Immunoassay, Others) Product( Equipment, Reagent and consumables) End user( Healthcare centers, Diagnostic laboratories, Others)

Abbott Laboratories, ACON Laboratories Inc., Bayer AG, Bio-Rad Laboratories Inc., Danaher Corp., Diazyme Laboratories Inc., EKF Diagnostics Holdings Plc, F. Hoffmann-La Roche Ltd., Siemens AG, Thermo Fisher Scientific Inc. are a few of the key vendors in the Hemoglobin Testing market.

North America will register the highest growth rate of 32.34% among the other regions. Therefore, the Hemoglobin Testing market in North America is expected to garner significant business opportunities for the vendors during the forecast period.

US, UK, China, Germany, Japan

  • Growing incidence of diabetes worldwide is the driving factor this market.

The Hemoglobin Testing market vendors should focus on grabbing business opportunities from the Chromatography segment as it accounted for the largest market share in the base year.